Approval · Notice of Compliance 1377 · 2000
STEMETIL: Notice of Compliance 1377
Issued November 14, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1377
- Date
- November 14, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antipsychotic - antiemetic
Products in this notice
Medicinal ingredients
- PROCHLORPERAZINE MESYLATE 5 MG per ML
- PROCHLORPERAZINE 10 MG per SUP
- PROCHLORPERAZINE MESYLATE 5 MG per 5ML
- PROCHLORPERAZINE MALEATE 5 MG per TAB
- PROCHLORPERAZINE MALEATE 10 MG per TAB